Clinician-facing neurosurgery CDS · Browser-local · Source-linkedRead more…
This tool is educational and informational. It does not replace clinical judgment. Verify benign peripheral nerve tumors and malignant-suspicion off-ramp against the cited source before acting.
Not prospectively validated. No clinical tool replaces bedside assessment.
This runs entirely in your browser; we store nothing. Even so, enter only clinical data (age, vitals, exam findings) -- not names, MRNs, or other identifiers.
Tarvinder Singh, MD -- Vascular Neurologist. March 2026.
Benign Peripheral Nerve Tumor Support
Observe, refer, or escalate malignant concern in peripheral nerve tumors.
Clarifying imaging and growth history will resolve this recommendation.
Clinical assessment
Neurologic exam and symptom assessment
Imaging
MRI characterization and feature flags
Context
Syndromic and anatomic modifiers
Enter symptoms, growth, or imaging features to move beyond observation.
Observation versus surgery cannot be chosen confidently until imaging and growth history are better defined.
When symptom burden is low but MRI characterization or interval growth is still unclear, confidence should stay low rather than assuming the lesion is routine-benign.
What would most change this
Clarifying imaging and growth history will resolve this recommendation.
Evidence: Limited -- 3 supporting sources
Brief Snapshot
What remains unclear
- Imaging characterization and growth history are incomplete.
What to watch
- New rapid growth, escalating pain, progressive neurologic deficit, or accumulating suspicious imaging features should trigger specialized reassessment rather than business-as-usual observation.
What would escalate
- False reassurance: Do not infer that the lesion is safely routine-benign before MRI characterization and growth history are clear.
Next steps
- Dedicated MRI review: Clarify lesion morphology before locking into observation or surgery.
- Document clinical baseline: Make sure pain, sensory findings, strength, and growth history are actually documented before the next decision point.
Evidence
Matched3
Reinforces that benign PNSTs are heterogeneous, often misdiagnosed or mistreated, and deserve deliberate specialist pathway selection rather than casual excision.
ExpertImaging anchor for the malignant-suspicion off-ramp: MRI feature combinations and diffusion restriction improve specificity for MPNST concern.
Meta-analysisBackground diagnostic anchor for why atypical, syndromic, and malignant-leaning lesions should not stay inside a benign algorithm once red flags accumulate.
ExpertSupportive1
Core practical anchor for the benign-surgical lane: pain, neurologic deficit, interval growth, and suspected malignancy were the main operative indications, with generally favorable symptom outcomes in an experienced peripheral nerve center.
CohortBackground5
Historical operative anchor for nerve-preservation principles: schwannomas and nonplexiform neurofibromas can often be resected with minimal deficit when functioning fascicles are preserved.
CohortSupports when the page surfaces nerve action potentials, triggered EMG, and intraoperative monitoring as relevant to nerve-sparing surgery near functionally important nerves.
ExpertSupports complementary PET and MRI escalation when routine benign assumptions are breaking down; malignant lesions more often show heterogeneous uptake, edema, cystic change, necrosis, or irregular margins.
CohortKeeps postoperative surveillance balanced: early residual enhancement can be nonspecific, and asymptomatic patients often do well without reflexively aggressive imaging responses.
CohortUseful caution anchor for less-appropriate-action guidance: unplanned biopsy of a routine-appearing benign nerve lesion can add neurological deficit or pain and should be routed thoughtfully.
CohortClinical Profiles
Sporadic schwannoma
Best-fit pattern for nerve-sparing microsurgical discussion when symptoms, interval growth, or deficit justify surgery.
- Pain, neurologic deficit, interval growth, or malignancy concern are the strongest practical triggers for surgery review.
- When surgery is chosen, preserving functioning fascicles should stay central to the operative plan.
Localized nonplexiform neurofibroma
Still a benign nerve-tumor pathway, but fascicular involvement can be less forgiving than classic schwannoma surgery.
- Benign surgery should not be treated like malignant resection, but the dissection plane can be less straightforward than schwannoma.
- Specialist evaluation matters because misclassification or mistreatment can leave lasting pain or function loss.
NF1 / plexiform / atypical context
This is where the benign algorithm should become more cautious, especially when pain, rapid growth, or suspicious imaging accumulates.
- NF1 or plexiform context lowers the threshold for malignant-suspicion escalation rather than routine benign follow-up.
- Once atypical imaging or accelerating symptoms appear, the page should pivot toward specialized workup rather than casual observation.